Monday, 25 May 2020

Novavax starts clinical trial of its coronavirus vaccine candidate - CNBC

No comments:

Post a Comment

Team uses AlphaFold AI to redesign gene-editing proteins to make them safer - Ars Technica

Team uses AlphaFold AI to redesign gene-editing proteins to make them safer    Ars Technica Precise DNA base editing using AlphaFold3-based ...